Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCi Investments Inc.
Latest Disclosed Ownership19,622 shares
Latest Disclosed Value $ 6,904,001
Ci Investments Inc. reports 5.34% decrease in ownership of AMGN / Amgen Inc.

On May 13, 2026 - Ci Investments Inc. filed a 13F-HR form disclosing ownership of 19,622 shares of Amgen Inc. (MX:AMGN) valued at $6,904,001 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 20,730 shares of Amgen Inc.. This represents a change in shares of -5.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AMGEN COM 031162100 19,622 -1,108 -5.34 6,904 1.75 0.0235
2026-02-12 2025-12-31 13F AMGEN COM 031162100 20,730 -1,719 -7.66 6,785 112,983.33 0.0297
2025-11-12 2025-09-30 13F AMGEN COM 031162100 22,449 -2,842 -11.24 6 -14.29 0.0230
2025-08-12 2025-06-30 13F AMGEN COM 031162100 25,291 1,134 4.69 7 0.00 0.0265
2025-05-13 2025-03-31 13F AMGEN COM 031162100 24,157 -4,850 -16.72 8 0.00 0.0317
2025-02-12 2024-12-31 13F AMGEN COM 031162100 29,007 -26,068 -47.33 8 -58.82 0.0285
2024-11-12 2024-09-30 13F AMGEN COM 031162100 55,075 -135 -0.24 18 0.00 0.0675
2024-08-12 2024-06-30 13F AMGEN COM 031162100 55,210 -7,803 -12.38 17 0.00 0.0679
2024-05-13 2024-03-31 13F AMGEN COM 031162100 63,013 11,006 21.16 18 21.43 0.0711
2024-02-12 2023-12-31 13F AMGEN COM 031162100 52,007 -6,890 -11.70 15 -6.67 0.0775
2023-11-13 2023-09-30 13F AMGEN COM 031162100 58,897 -1,550 -2.56 16 15.38 0.0883
2023-08-11 2023-06-30 13F AMGEN COM 031162100 60,447 -1,897 -3.04 13 -13.33 0.0677
2023-05-12 2023-03-31 13F AMGEN COM 031162100 62,344 15,001 31.69 15 25.00 0.0758
2023-02-10 2022-12-31 13F AMGEN COM 031162100 47,343 -5,006 -9.56 12 -99.90 0.0629
2022-11-14 2022-09-30 13F AMGEN COM 031162100 52,349 1,155 2.26 11,799 -5.27 0.0612
2022-08-12 2022-06-30 13F AMGEN COM 031162100 51,194 -4,241 -7.65 12,456 -7.08 0.0581
2022-05-12 2022-03-31 13F AMGEN COM 031162100 55,435 5,677 11.41 13,405 19.75 0.0493
2022-02-11 2021-12-31 13F AMGEN COM 031162100 49,758 7,571 17.95 11,194 24.78 0.0386
2021-11-12 2021-09-30 13F AMGEN COM 031162100 42,187 -10,858 -20.47 8,971 -30.62 0.0334
2021-08-13 2021-06-30 13F AMGEN COM 031162100 53,045 -52 -0.10 12,930 -2.13 0.0474
2021-05-13 2021-03-31 13F AMGEN COM 031162100 53,097 -8,562 -13.89 13,211 -6.81 0.0557
2021-02-09 2020-12-31 13F AMGEN COM 031162100 61,659 19,566 46.48 14,177 32.52 0.0625
2020-11-09 2020-09-30 13F AMGEN COM 031162100 42,093 6,551 18.43 10,698 27.62 0.0532
2020-08-07 2020-06-30 13F AMGEN COM 031162100 35,542 -7,609 -17.63 8,383 -4.17 0.0447
2020-08-07 2020-03-31 13F AMGEN COM 031162100 43,151 -327,672 -88.36 8,748 -90.21 0.0531
2020-02-11 2019-12-31 13F AMGEN COM 031162100 370,823 333,372 890.16 89,394 1,133.53 0.4540
2019-11-08 2019-09-30 13F AMGEN COM 031162100 37,451 37,451 7,247 0.0374
2019-08-12 2019-06-30 13F AMGEN COM 031162100 0 -2,397 -100.00 0 -100.00
2019-05-15 2019-03-31 13F AMGEN COM 031162100 2,397 -1,460 -37.85 455 -39.41 0.0026
2019-02-15 2018-12-31 13F AMGEN COM 031162100 3,857 3,857 751 0.0048
2018-05-11 2018-03-31 13F AMGEN COM 031162100 0 -37,898 -100.00 0 -100.00
2018-05-11 2017-12-31 13F/A-1 AMGEN COM 031162100 37,898 -10,491 -21.68 6,590 -26.96 0.0676
2018-02-02 2017-12-31 13F AMGEN COM 031162100 37,898 -10,491 6,590
2018-05-11 2017-09-30 13F/A-1 AMGEN COM 031162100 48,389 -832 -1.69 9,022 6.43 0.0881
2017-11-06 2017-09-30 13F AMGEN COM 031162100 127,039 77,818 23,686
2017-08-10 2017-06-30 13F AMGEN COM 031162100 49,221 49,221 8,477 0.0918
2017-05-05 2017-03-31 13F AMGEN COM 031162100 0 -99,400 -100.00 0 -100.00
2017-02-06 2016-12-31 13F AMGEN COM 031162100 99,400 99,400 14,533 0.1591
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.